Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

Author: Klonoff David C.   Buse John B.   Nielsen Loretta L.   Guan Xuesong   Bowlus Christopher L.   Holcombe John H.   Wintle Matthew E.   Maggs David G.  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.24, Iss.1, 2008-01, pp. : 275-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract